Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001343742 | SCV001537748 | uncertain significance | not provided | 2022-03-27 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 78 of the SLC34A3 protein (p.Gly78Arg). This variant is present in population databases (rs756241784, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with SLC34A3-related conditions. ClinVar contains an entry for this variant (Variation ID: 1040148). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002493762 | SCV002775118 | uncertain significance | Autosomal recessive hypophosphatemic bone disease | 2021-12-25 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV002493762 | SCV004708190 | pathogenic | Autosomal recessive hypophosphatemic bone disease | 2024-03-08 | no assertion criteria provided | clinical testing |